Brief Title
Aminoglycosides and Duct
Official Title
The Effect of Aminoglycosides on Ductus in Preterm Infants
Brief Summary
The aim of the study is to assess the effect of aminoglycoside treatment on ductal closure in preterms
Study Type
Observational
Primary Outcome
ductal closure
Condition
Patent Ductus Arteriosus
Intervention
echocardiography
Study Arms / Comparison Groups
exposure to aminoglicosides
Description: preterm receiving aminoglycosides
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Diagnostic Test
Estimated Enrollment
60
Start Date
July 2021
Completion Date
December 2022
Primary Completion Date
July 2022
Eligibility Criteria
Inclusion Criteria: infants born at or above 32 weeks of gestation - Exclusion Criteria: - infants who are unlikely to survive or have congenital heart defects
Gender
All
Ages
N/A - 3 Weeks
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Contacts
, ,
Administrative Informations
NCT ID
NCT04415554
Organization ID
CMC-19-0110-CTIL
Responsible Party
Principal Investigator
Study Sponsor
Carmel Medical Center
Study Sponsor
, ,
Verification Date
February 2021